Can binocular diplopia be localized by whether it is monocular or binocular and by the eye misalignment pattern?

Binocular diplopia is a localization problem rather than a diagnosis: ocular-motor nerve dysfunction, brainstem/supranuclear disease, and other urgent disorders can produce similar subjective “double vision.” In a 69-year-old, acute onset or accompanying neurologic symptoms merits particular caution.

Clinical localization

• Monocular versus binocular testing is foundational. Diplopia that persists with either eye viewing alone points toward ocular/optical mechanisms; diplopia that disappears when either eye is covered is binocular and usually reflects ocular misalignment.
• The misalignment pattern and gaze dependence refine localization. CN VI dysfunction typically produces impaired abduction and horizontal diplopia worse at distance or toward the affected side. CN IV dysfunction commonly causes vertical/oblique diplopia, often worse on downgaze and with head tilt. CN III palsy impairs adduction, elevation, and depression and may include ptosis.
• Cranial-nerve palsies were identified in 70.7% of diplopia presentations in one adult single-center cohort, though this is not a population-prevalence estimate.

Central mechanisms and warning signs

• Brainstem or supranuclear lesions can disrupt conjugate gaze and vestibular–ocular pathways, producing binocular diplopia through internuclear ophthalmoplegia, skew deviation, gaze palsy, nystagmus, or abnormal saccades/pursuit.
• Vertigo, ataxia, dysarthria, crossed sensory/motor findings, headache, or pupillary abnormalities increase concern for central pathology. Intracranial tumors comprised 4.4% of binocular-diplopia cases in one cohort; a review estimated brainstem/cerebellar disorders at about 10%.

Ischemia cannot be inferred from symptoms

• Diplopia—even when apparently isolated—does not establish a microvascular/ischemic cause. Among 109 adults aged ≥50 years with acute isolated CN III/IV/VI palsy, 18 (16.5%) had non-microvascular causes on MRI and clinical assessment, including neoplasm, infarction, inflammation, pituitary apoplexy, and giant-cell arteritis.
• Bottom line: Occlusion testing, alignment/motility examination, neurologic findings, and appropriately selected imaging—not diplopia symptoms alone—determine localization and whether ischemia is plausible.